Milo Health
OperatingMilo Health, Inc.
Healthcare · New York, NY · Founded 2017
Better, simpler prescription care
Financials
FY2020–FY2024 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inBlue bars are the pre-money valuation the company stated for a priced round.
Share price over rounds
Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.
Cap table
Principal holders% as the filing states it, Apr 9, 2025
- Robert Siegel53.0%of company
- Ameer Youssef21.7%of company
Sold to the crowd
- Reg CF · Sep 20229,869 shares at $10.00$98.7K· 25 investors
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
6 people
Brad is a "double threat" with degrees in pharmacy and law. He has held many positions at the intersection of American law and pharmacy practice, most recently on the team that arranged for CVS/Caremark to take over the pharmacy business inside Target stores.
Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 3 of 4 annual reports (FY2022–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 9 filings on EDGAR- Form C-ARApr 9, 20250001717109-25-000001EDGAR
- Form C-TRApr 9, 20250001717109-25-000003EDGAR
- Form C-ARApr 5, 20240001665160-24-000311EDGAR
- Form C-ARMay 19, 20230001665160-23-001270EDGAR
- Form C-UDec 29, 20220001665160-22-003136EDGAR
- Form C/ANov 22, 20220001665160-22-002953EDGAR
- Form CAug 29, 20220001665160-22-002309EDGAR
- Form DMay 4, 20200001717109-20-000001EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.